GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,600.00p
   
  • Change Today:
    -4.50p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.96m
  • Volume: 3,788,158
  • Market Cap: £66,319m
  • RiskGrade: 129

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
16-Apr-24 Buy Dividends Hal Barron 3,202.70p 2,906,213 £93,077,316.08
16-Apr-24 Buy Dividends Emma Walmsley 1,611.28p 1,840,922 £29,662,409.10
16-Feb-24 Sell Emma Walmsley 1,657.97p 139,792 £2,317,709.49
24-Aug-23 Sell Hal Barron 3,461.74p 58,157 £2,013,244.20
24-Aug-23 Sell Hal Barron 3,461.74p 19,446 £673,169.98
23-Jun-23 Buy Julie Brown 1,429.13p 22,500 £321,554.25
01-Feb-24 Buy Julie Brown 1,582.80p 19,360 £306,430.08
22-Feb-24 Buy Hal Barron 1,737.62p 5,547 £96,385.75
16-May-24 Buy Dividends Hal Barron 3,542.25p 2,433 £86,183.04
23-Jun-23 Buy Jonathan Symonds 1,439.79p 6,000 £86,387.40
17-Aug-23 Buy Dividends Hal Barron 2,734.98p 2,919 £79,830.71
16-Nov-23 Buy Dividends Hal Barron 1,387.09p 5,606 £77,760.14
16-Jan-24 Buy Dividends Hal Barron 2,002.20p 3,947 £79,026.83
15-Jan-24 Buy Dividends Emma Walmsley 1,556.40p 4,947 £76,999.84
16-Oct-23 Buy Dividends Emma Walmsley 1,519.80p 5,020 £76,297.02
20-Jun-23 Buy Charles Bancroft 3,474.03p 1,646 £57,182.53
20-Mar-24 Buy Charles Bancroft 1,638.72p 3,306 £54,176.05
01-Feb-24 Buy Jonathan Symonds 1,570.62p 3,500 £54,971.70
20-Dec-23 Buy Charles Bancroft 2,897.38p 1,757 £50,906.88
20-Sep-23 Buy Charles Bancroft 1,540.17p 3,382 £52,088.46

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,600.00p
Change Today -4.50p
% Change -0.28 %
52 Week High 1,812.50
52 Week Low 1,316.00
Volume 3,788,158
Shares Issued 4,144.96m
Market Cap £66,319m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.44% below the market average55.44% below the market average55.44% below the market average55.44% below the market average55.44% below the market average
37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average
Price Trend
33.91% above the market average33.91% above the market average33.91% above the market average33.91% above the market average33.91% above the market average
54.72% above the sector average54.72% above the sector average54.72% above the sector average54.72% above the sector average54.72% above the sector average
Income
16.31% above the market average16.31% above the market average16.31% above the market average16.31% above the market average16.31% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
20.4% below the market average20.4% below the market average20.4% below the market average20.4% below the market average20.4% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 8
Buy 4
Neutral 10
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 17-Jun-2024

Time Volume / Share Price
16:50 2,189 @ 1,600.00p
16:47 3,937 @ 1,597.05p
16:35 20,000 @ 1,599.06p
16:35 10,941 @ 1,600.00p
16:35 9,836 @ 1,600.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page